Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA.
Curr Med Res Opin. 2024 Mar;40(3):431-439. doi: 10.1080/03007995.2024.2303090. Epub 2024 Jan 22.
Real-world data is crucial to inform existing opportunistic colorectal cancer (CRC) prevention programs. This study aimed to assess CRC screening adherence and utilization of various screening modalities within a Primary Care network over a three-year period (2017-2019).
A retrospective review of individuals aged 50-75 years at average CRC risk, with at least one clinic visit in the previous 24 months. The primary outcome, CRC screening adherence (overall and by modality) was examined among the entire eligible population and newly adherent individuals each calendar year. The final sample included 107,366 patients and 218,878 records.
Overall CRC screening adherence increased from 71% in 2017 to 78% in 2019. For "up-to-date" individuals, colonoscopy was the predominant modality (accounting for approximately 74%, versus 4% of adherence for non-invasive options). However, modality utilization trends changed over time in these individuals: mt-sDNA increased 10.2-fold, followed by FIT (1.6-fold) and colonoscopy (1.1-fold). Among newly adherent individuals, the proportion screened by colonoscopy and FOBT decreased over time (89% to 80% and 2.4% to 1.2%, respectively), while uptake of FIT and mt-sDNA increased (7.7% to 11.5% and 0.9% to 6.8%, respectively). Notably, FIT and mt-sDNA increases were most evident in age and race-ethnicity groups with the lowest screening rates.
In an opportunistic CRC screening program, adherence increased but remained below the national 80% goal. While colonoscopy remained the most utilized modality, new colonoscopy uptake declined, compared with rising mt-sDNA and FIT utilization. Among minority populations, new uptake increased most with mt-sDNA and FIT.
真实世界的数据对于现有机会性结直肠癌(CRC)预防计划至关重要。本研究旨在评估在三年期间(2017-2019 年),初级保健网络中 CRC 筛查的依从性和各种筛查方式的利用情况。
对平均 CRC 风险为 50-75 岁且在过去 24 个月内至少有一次就诊的个体进行回顾性审查。在整个合格人群中以及每年新符合条件的个体中,检查 CRC 筛查的依从性(总体和按方式)。最终样本包括 107366 名患者和 218878 条记录。
总体 CRC 筛查的依从性从 2017 年的 71%增加到 2019 年的 78%。对于“最新”的个体,结肠镜检查是主要的方式(占约 74%,而非侵入性选择的依从性为 4%)。然而,在这些个体中,模式利用趋势随时间而变化:mt-sDNA 增加了 10.2 倍,其次是 FIT(1.6 倍)和结肠镜检查(1.1 倍)。在新符合条件的个体中,结肠镜检查和 FOBT 的筛查比例随时间降低(分别从 89%降至 80%和从 2.4%降至 1.2%),而 FIT 和 mt-sDNA 的使用率增加(分别从 7.7%升至 11.5%和从 0.9%升至 6.8%)。值得注意的是,在筛查率最低的年龄和种族群体中,FIT 和 mt-sDNA 的使用率增加最为明显。
在机会性 CRC 筛查计划中,依从性增加,但仍低于全国 80%的目标。虽然结肠镜检查仍然是最常用的方式,但与 mt-sDNA 和 FIT 的使用增加相比,新的结肠镜检查使用率下降。在少数民族群体中,mt-sDNA 和 FIT 的新使用率增加最多。